Indications and uses
cures most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis) effectively relieves itching cracking burning discomfort which can accompany these conditions
cures most athlete's foot (tinea pedis), jock itch (tinea cruris), and ringworm (tinea corporis) effectively relieves itching cracking burning discomfort which can accompany these conditions
This product is not effective on the scalp or nails For best results, follow directions and continue treatment for length of time indicated. For athlete's foot and ringworm: use daily for 4 weeks. For jock itch: use daily for 2 weeks. clean the affected area and dry thoroughly apply a thin layer of the product over affected area twice daily (morning and night) or as directed by a doctor supervise children in the u...
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Drug Facts
Clotrimazole USP, 1%
Antifungal
which can accompany these conditions
For external use only
Ask a doctor before use
When using this product
Stop use and ask a doctor if
Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.
For athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes; change shoes and socks at least once daily
polyethylene glycol 400
Call 1-866-923-4914
Distributed by:
Taro Pharmaceuticals U.S.A., Inc.
Hawthorne, NY 10532
Clotrimazole Topical Solution USP 1%
| Class | Version | Type | Effective |
|---|---|---|---|
| CLOTRIMAZOLE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b64d2752-34ef-378a-1f4f-8bff32b0d1ae | Product name | 4 | 20250626 |
| cb7783e0-feaa-7e56-fb3b-d43b6efa77c9 | Product name | 2 | 20250121 |
| f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6 | Product name | 2 | 20151106 |
| f5395dd2-4395-d8c6-3477-8c2d4a2f951c | Product name | 1 | 20140508 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2037-1 | ML - Milliliter | 51672-2037 | 62fe0879-e7b6-4c4c-b367-63ff1652c51b | 1 | 2012-07-24 |
| 51672-2158-1 | ML - Milliliter | 51672-2158 | f0efb906-a14a-4d46-a97f-ffe051818ede | 1 | 2025-02-10 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Clotrimazole | ACTIVE INGREDIENT | G07GZ97H65 | 1 | |
| Clotrimazole | ACTIVE MOIETY | G07GZ97H65 | 1 | |
| polyethylene glycol 400 | INACTIVE INGREDIENT | B697894SGQ | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51672-2037 | 51672-2037-1 |
| 51672-2158 | 51672-2158-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| CLOTRIMAZOLE | G07GZ97H65 | ACTIB |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| CLOTRIMAZOLE | G07GZ97H65 | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 4 | 2025-07-01 | full-release | 2026-06-01 01:06:10 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| polyethylene glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION / TOPICAL | 11100 mg | ||
| polyethylene glycol 400 | POLYETHYLENE GLYCOL 400 | B697894SGQ | SOLUTION / TOPICAL | 11100 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clotrimazole | CLOTRIMAZOLE | Sun Pharmaceutical Industries, Inc. | 13a14d3c-bfce-42b5-8463-4ec69e94774e | 2026-06-03 | Warnings | 51672-2037-1 51672-2158-1 51672-2158 51672-2037 51672215801 51672203701 5353c019-612d-669e-e063-6294a90ab75f 13a14d3c-bfce-42b5-8463-4ec69e94774e |
Adverse event summaries are temporarily unavailable. Other product information remains available.